Visser G - Search Results

1

PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats.

Brouwers A, Verel I, Van Eerd J, Visser G, Steffens M, Oosterwijk E, Corstens F, Oyen W, Van Dongen G, Boerman O. Brouwers A, et al. Among authors: visser g. Cancer Biother Radiopharm. 2004 Apr;19(2):155-63. doi: 10.1089/108497804323071922. Cancer Biother Radiopharm. 2004. PMID: 15186595 Free article.

2

Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.

Verel I, Visser GW, Boerman OC, van Eerd JE, Finn R, Boellaard R, Vosjan MJ, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. Cancer Biother Radiopharm. 2003 Aug;18(4):655-61. doi: 10.1089/108497803322287745. Cancer Biother Radiopharm. 2003. PMID: 14503961

3

Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Verel I, Visser GW, Boellaard R, Boerman OC, van Eerd J, Snow GB, Lammertsma AA, van Dongen GA. Verel I, et al. J Nucl Med. 2003 Oct;44(10):1663-70. J Nucl Med. 2003. PMID: 14530484 Free article.

4

89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.

Verel I, Visser GW, Boellaard R, Stigter-van Walsum M, Snow GB, van Dongen GA. Verel I, et al. J Nucl Med. 2003 Aug;44(8):1271-81. J Nucl Med. 2003. PMID: 12902418 Free article.

5

High-quality 124I-labelled monoclonal antibodies for use as PET scouting agents prior to 131I-radioimmunotherapy.

Verel I, Visser GW, Vosjan MJ, Finn R, Boellaard R, van Dongen GA. Verel I, et al. Eur J Nucl Med Mol Imaging. 2004 Dec;31(12):1645-52. doi: 10.1007/s00259-004-1632-8. Epub 2004 Jul 31. Eur J Nucl Med Mol Imaging. 2004. PMID: 15290121

6

The promise of immuno-PET in radioimmunotherapy.

Verel I, Visser GW, van Dongen GA. Verel I, et al. J Nucl Med. 2005 Jan;46 Suppl 1:164S-71S. J Nucl Med. 2005. PMID: 15653665 Free article. Review.

7

Immuno-PET: a navigator in monoclonal antibody development and applications.

van Dongen GA, Visser GW, Lub-de Hooge MN, de Vries EG, Perk LR. van Dongen GA, et al. Among authors: visser gw. Oncologist. 2007 Dec;12(12):1379-89. doi: 10.1634/theoncologist.12-12-1379. Oncologist. 2007. PMID: 18165614 Free article. Review.

8

Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.

Perk LR, Stigter-van Walsum M, Visser GW, Kloet RW, Vosjan MJ, Leemans CR, Giaccone G, Albano R, Comoglio PM, van Dongen GA. Perk LR, et al. Among authors: visser gw. Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1857-67. doi: 10.1007/s00259-008-0774-5. Epub 2008 May 20. Eur J Nucl Med Mol Imaging. 2008. PMID: 18491091

9

89Zr-PET radiochemistry in the development and application of therapeutic monoclonal antibodies and other biologicals.

Vugts DJ, Visser GW, van Dongen GA. Vugts DJ, et al. Curr Top Med Chem. 2013;13(4):446-57. doi: 10.2174/1568026611313040005. Curr Top Med Chem. 2013. PMID: 23432007 Review.

10

Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2.

van Dongen GA, Leverstein H, Roos JC, Quak JJ, van den Brekel MW, van Lingen A, Martens HJ, Castelijns JA, Visser GW, Meijer CJ, et al. van Dongen GA, et al. Among authors: visser gw. Cancer Res. 1992 May 1;52(9):2569-74. Cancer Res. 1992. PMID: 1568225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,006 results

Search Page

Filters